The National Biomarker Development Alliance at Arizona State University, a non-profit organization with the mission to create the needed standards to support biomarker development and advance precision medicine, was announced Jan. 13 at the National Press Club in Washington D.C.
Arizona Gov. Jan Brewer during her recent "State of the State" address called for a dedicated funding source for the Translational Genomics Research Institute to serve as a catalyst in developing the state's bioscience industry.
Top bioscience news, December 5-12, 2013: Venture Madness pits 64 companies in bracket-style competition; Cancer Treatment Centers of America’s hospital in Goodyear continues growth; Jerry Colangelo to keynote new startup conference
Top bioscience news, November 24-December 5, 2013: Banner Alzheimer’s Institute studies infants with “Alzheimer’s gene”; Three Phoenix institutions receive grant to study brain injuries; Arizona should stay committed to the biosciences
Yolia Health, which has developed a non-invasive procedure for treating vision problems, was named the Innovator of the Year for startup companies during the 10th annual Arizona Governor’s Celebration of Innovation Awards.
Top bioscience news, October 7-17, 2013: TGen opens Center for Rare Childhood Disorders; Rapid growth of Accelerate Diagnostics driving innovation; Bioscience professor presents portable, speedy DNA identification system
The National Science Foundation (NSF) has awarded a $50 million renewal grant to a multi-institution collaborative headquartered at the University of Arizona's BIO5 Institute to create a national cyberinfrastructure for the biological sciences.
Banner Alzheimer’s Institute in Phoenix has been awarded a $33 million federal grant for a new study that will test an experimental drug on people who are at the greatest risk of developing Alzheimer’s with hopes of discovering a treatment to prevent the disease.
A new drug combination tested in metro Phoenix to treat late-stage pancreatic cancer was approved by the U.S. Food and Drug Administration after showing the combination of Abraxane and gemcitabine helped 35 percent of patients live at least one year.
The Arizona SciTech Festival hosted its kick-off conference on Sept. 4 in Scottsdale, featuring panels, speakers and a chance to collaborate in preparation for the upcoming five-week festival planned in February and March.